Evermay Wealth Management LLC Boosts Stock Position in Danaher Corporation $DHR

Evermay Wealth Management LLC lifted its position in Danaher Corporation (NYSE:DHR) by 2.4% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 10,564 shares of the conglomerate’s stock after purchasing an additional 246 shares during the quarter. Evermay Wealth Management LLC’s holdings in Danaher were worth $2,090,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of DHR. Nuveen LLC purchased a new position in shares of Danaher in the 1st quarter worth about $833,941,000. Invesco Ltd. lifted its stake in shares of Danaher by 44.5% in the 1st quarter. Invesco Ltd. now owns 4,708,578 shares of the conglomerate’s stock valued at $965,259,000 after acquiring an additional 1,450,703 shares during the last quarter. Baird Financial Group Inc. lifted its stake in shares of Danaher by 290.6% in the 1st quarter. Baird Financial Group Inc. now owns 1,441,706 shares of the conglomerate’s stock valued at $295,550,000 after acquiring an additional 1,072,617 shares during the last quarter. Generation Investment Management LLP lifted its stake in shares of Danaher by 33.2% in the 1st quarter. Generation Investment Management LLP now owns 3,178,124 shares of the conglomerate’s stock valued at $651,515,000 after acquiring an additional 791,662 shares during the last quarter. Finally, Parnassus Investments LLC lifted its stake in shares of Danaher by 23.3% in the 1st quarter. Parnassus Investments LLC now owns 3,828,024 shares of the conglomerate’s stock valued at $784,745,000 after acquiring an additional 722,636 shares during the last quarter. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other news, Director Teri List sold 2,778 shares of the stock in a transaction that occurred on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the transaction, the director owned 20,751 shares of the company’s stock, valued at approximately $4,379,706.06. This represents a 11.81% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 11.20% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on DHR shares. Evercore ISI boosted their target price on Danaher from $226.00 to $245.00 and gave the company an “outperform” rating in a research note on Tuesday, October 7th. Guggenheim reissued a “buy” rating and issued a $250.00 target price on shares of Danaher in a research note on Wednesday, July 23rd. Barclays reissued an “overweight” rating and issued a $225.00 target price (up previously from $215.00) on shares of Danaher in a research note on Tuesday, June 24th. Robert W. Baird boosted their target price on Danaher from $229.00 to $236.00 and gave the company an “outperform” rating in a research note on Wednesday, October 15th. Finally, Redburn Partners set a $220.00 price target on Danaher in a research report on Wednesday, October 8th. Seventeen analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $245.00.

Danaher Trading Down 0.8%

DHR opened at $209.14 on Monday. The business has a 50 day simple moving average of $201.60 and a two-hundred day simple moving average of $197.24. The firm has a market capitalization of $149.76 billion, a price-to-earnings ratio of 44.50, a PEG ratio of 2.98 and a beta of 0.77. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22. Danaher Corporation has a one year low of $171.00 and a one year high of $275.51.

Danaher (NYSE:DHR) last released its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, beating analysts’ consensus estimates of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The business had revenue of $5.94 billion during the quarter, compared to analyst estimates of $5.83 billion. During the same quarter in the prior year, the company posted $1.72 EPS. Danaher’s quarterly revenue was up 3.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Analysts predict that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be given a $0.32 dividend. The ex-dividend date of this dividend is Friday, September 26th. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. Danaher’s dividend payout ratio is currently 27.23%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.